CDT Insider Filing: 35,000 RSUs Vest Immediately; 15,000 Options Granted
Rhea-AI Filing Summary
CDT Equity Inc. director Simon Jeremy Fry received equity awards disclosed on Form 4 showing two grants tied to his service. He was granted 35,000 restricted stock units (RSUs) on 08/12/2025 that vested immediately and were valued at approximately $60,900 based on the closing share price that day. At the 2025 annual meeting he was also granted 15,000 stock options with an exercise price of $1.89, exercisable immediately and expiring on 08/05/2035. After these transactions Mr. Fry beneficially owned 36,956 shares of common stock and held options covering 15,000 shares.
Positive
- 35,000 RSUs granted and vested immediately, providing clear compensation tied to service
- 15,000 stock options granted with immediate exercisability and a specified $1.89 strike price
- RSU value disclosed (~$60,900), giving transparent economic context for the grant
Negative
- None.
Insights
TL;DR: Insider compensation through RSUs and options increases director's stake but is a routine corporate grant.
The report documents compensation-related equity grants rather than open-market trading. The immediate vesting of 35,000 RSUs and 15,000 immediately exercisable options signals standard service-based awards to align management/director incentives with shareholders. The combined grants add modestly to outstanding share-based obligations; the RSU value (~$60,900) is disclosed and the option strike ($1.89) is explicit. For investors, this is governance/compensation disclosure without evidence of unusual insider trading.
TL;DR: Grants appear to be standard director compensation disclosed under Section 16 rules; immediate vesting is notable but documented.
The filing shows the awards were granted under the company’s equity plan and vest immediately, which should be reviewed in the context of the plan’s terms and peer practices. The filing clearly identifies the form of ownership as direct and provides the full exercise/expiration details for the options ($1.89, expiring 08/05/2035), enabling an assessment of potential dilution and governance alignment from public records.